Frankfurt - Delayed Quote EUR

RegenETP, Inc. (NJT.F)

0.2200

0.0000

(0.00%)

At close: June 15 at 10:03 AM GMT+2

Key Events

Advanced Chart

Loading Chart for NJT.F

9/21 12:03 PM

DELL

Previous Close 0.2200
Open 0.1996
Bid --
Ask --
Day's Range 0.1996 - 0.2200
52 Week Range 0.1996 - 1.7200
Volume 100
Avg. Volume 23
Market Cap (intraday) 1.623M
Beta (5Y Monthly) 1.78
PE Ratio (TTM) --
EPS (TTM) -0.6100
Earnings Date Apr 26, 2024 - Apr 27, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

www.polarityte.com